Pancreatitis Trial, Recruiting (NCT07080697)

Pancreatitis Trial, Recruiting NCT07080697 Sponsor: Zhejiang University Condition: Pancreatitis

Printed from Voxsanity (voxsanity.com.au) — NCT07080697 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged between 18 and 75 years.
People who have acute necrotising pancreatitis (a severe form of pancreatic inflammation where tissue dies) that has been complicated by increased blood pressure in certain blood vessels on the left side of the abdomen (confirm with trial site).
People who are having open surgery to remove infected dead tissue from the pancreas.

Who may not be able to join:

People who had heart, lung, liver, kidney, or other organ failure before their pancreatitis began.
People who had pre-existing liver scarring (cirrhosis) or other conditions that may have already caused high pressure in the portal blood vessels before their pancreatitis began.
People who had a pre-existing blood or bone marrow disorder before their pancreatitis began.
People whose surgery to remove infected pancreatic tissue is being performed using keyhole (laparoscopic) or nephroscope-assisted techniques, rather than open surgery.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 086-18058715288

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07080697

Sponsor: Zhejiang University

Phase: Not Applicable

Status: Recruiting

Condition: Pancreatitis

Trial contact: 086-18058715288

More information: https://clinicaltrials.gov/study/NCT07080697

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged between 18 and 75 years.
People who have acute necrotising pancreatitis (a severe form of pancreatic inflammation where tissue dies) that has been complicated by increased blood pressure in certain blood vessels on the left side of the abdomen (confirm with trial site).
People who are having open surgery to remove infected dead tissue from the pancreas.

Who may not be able to join:

People who had heart, lung, liver, kidney, or other organ failure before their pancreatitis began.
People who had pre-existing liver scarring (cirrhosis) or other conditions that may have already caused high pressure in the portal blood vessels before their pancreatitis began.
People who had a pre-existing blood or bone marrow disorder before their pancreatitis began.
People whose surgery to remove infected pancreatic tissue is being performed using keyhole (laparoscopic) or nephroscope-assisted techniques, rather than open surgery.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Zhejiang University

Registry

ClinicalTrials.gov

Start date

30 July 2025

Est. completion

28 February 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Length of hospital stay after debridement; Degree of pancreatic sinistral portal hypertension

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov